These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14972750)

  • 41. Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides.
    Morishita R; Gibbons GH; Ellison KE; Nakajima M; von der Leyen H; Zhang L; Kaneda Y; Ogihara T; Dzau VJ
    J Clin Invest; 1994 Apr; 93(4):1458-64. PubMed ID: 8163650
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of human telomerase activity by antisense phosphorothioate oligonucleotides encapsulated with the transfection reagent, FuGENE6, in HeLa cells.
    Tamura Y; Tao M; Miyano-Kurosaki N; Takai K; Takaku H
    Antisense Nucleic Acid Drug Dev; 2000 Apr; 10(2):87-96. PubMed ID: 10805159
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A methodology to study intracellular distribution of nanoparticles in brain endothelial cells.
    Garcia-Garcia E; Andrieux K; Gil S; Kim HR; Le Doan T; Desmaële D; d'Angelo J; Taran F; Georgin D; Couvreur P
    Int J Pharm; 2005 Jul; 298(2):310-4. PubMed ID: 15923094
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cytosolic delivery of antisense oligonucleotides by listeriolysin O-containing liposomes.
    Mathew E; Hardee GE; Bennett CF; Lee KD
    Gene Ther; 2003 Jul; 10(13):1105-15. PubMed ID: 12808441
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cellular fate of oligonucleotides when delivered by nanocapsules of poly(isobutylcyanoacrylate).
    Toub N; Angiari C; Eboué D; Fattal E; Tenu JP; Le Doan T; Couvreur P
    J Control Release; 2005 Aug; 106(1-2):209-13. PubMed ID: 15951045
    [TBL] [Abstract][Full Text] [Related]  

  • 46. On the role of methacrylic acid copolymers in the intracellular delivery of antisense oligonucleotides.
    Yessine MA; Meier C; Petereit HU; Leroux JC
    Eur J Pharm Biopharm; 2006 May; 63(1):1-10. PubMed ID: 16364618
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polyion complex micelles with protein-modified corona for receptor-mediated delivery of oligonucleotides into cells.
    Vinogradov S; Batrakova E; Li S; Kabanov A
    Bioconjug Chem; 1999; 10(5):851-60. PubMed ID: 10502353
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-proliferative effects of unmodified antisense oligodeoxynucleotides targeted against c-raf mRNA: use of poly (lysine/serine) copolymers or cationic lipopolyamines.
    Aoki Y; Kawa S; Karasawa Y; Horiuchi A; Kiyosawa K
    Clin Exp Pharmacol Physiol; 1998 Sep; 25(9):702-5. PubMed ID: 9750959
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phosphorothioate antisense oligonucleotides induce the formation of nuclear bodies.
    Lorenz P; Baker BF; Bennett CF; Spector DL
    Mol Biol Cell; 1998 May; 9(5):1007-23. PubMed ID: 9571236
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Uptake, intracellular distribution, and stability of oligodeoxynucleotide phosphorothioate by Schistosoma mansoni.
    Tao LF; Marx KA; Wongwit W; Jiang Z; Agrawal S; Coleman RM
    Antisense Res Dev; 1995; 5(2):123-9. PubMed ID: 7580116
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vascular smooth muscle cell proliferation and regrowth after mechanical injury in vitro are Egr-1/NGFI-A-dependent.
    Santiago FS; Atkins DG; Khachigian LM
    Am J Pathol; 1999 Sep; 155(3):897-905. PubMed ID: 10487847
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasmodium falciparum: effect of chemical structure on efficacy and specificity of antisense oligonucleotides against malaria in vitro.
    Barker RH; Metelev V; Coakley A; Zamecnik P
    Exp Parasitol; 1998 Jan; 88(1):51-9. PubMed ID: 9501848
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Processing of chimeric antisense oligonucleotides by human vascular smooth muscle cells and human atherosclerotic plaque. Implications for antisense therapy of restenosis after angioplasty.
    Pickering JG; Isner JM; Ford CM; Weir L; Lazarovits A; Rocnik EF; Chow LH
    Circulation; 1996 Feb; 93(4):772-80. PubMed ID: 8641007
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A nonantisense sequence-selective effect of a phosphorothioate oligodeoxynucleotide directed against the epidermal growth factor receptor in A431 cells.
    Coulson JM; Poyner DR; Chantry A; Irwin WJ; Akhtar S
    Mol Pharmacol; 1996 Aug; 50(2):314-25. PubMed ID: 8700139
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bolus intravenous injection of phosphorothioate oligonucleotides causes hypotension by acting as alpha(1)-adrenergic receptor antagonists.
    Iversen PL; Cornish KG; Iversen LJ; Mata JE; Bylund DB
    Toxicol Appl Pharmacol; 1999 Nov; 160(3):289-96. PubMed ID: 10544063
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antisense Ca(2+)-calmodulin dependent protein kinase oligonucleotide inhibits bFGF-induced proliferation of rat vascular smooth muscle cells.
    Huang SL; Ding B; Li J; Yu QS; Guo ZG
    Acta Pharmacol Sin; 2000 Mar; 21(3):229-33. PubMed ID: 11324421
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics and organ clearance of a 3'-biotinylated, internally [32P]-labeled phosphodiester oligodeoxynucleotide coupled to a neutral avidin/monoclonal antibody conjugate.
    Kang YS; Boado RJ; Pardridge WM
    Drug Metab Dispos; 1995 Jan; 23(1):55-9. PubMed ID: 7720525
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antisense oligodeoxyribonucleotides: stability and distribution after intracerebral injection into rat brain.
    Szklarczyk A; Kaczmarek L
    J Neurosci Methods; 1995 Aug; 60(1-2):181-7. PubMed ID: 8544478
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Complete inactivation of target mRNA by biotinylated antisense oligodeoxynucleotide-avidin conjugates.
    Boado RJ; Pardridge WM
    Bioconjug Chem; 1994; 5(5):406-10. PubMed ID: 7849069
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clearance kinetics, biodistribution, and organ saturability of phosphorothioate oligodeoxynucleotides in mice.
    Rifai A; Brysch W; Fadden K; Clark J; Schlingensiepen KH
    Am J Pathol; 1996 Aug; 149(2):717-25. PubMed ID: 8702009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.